Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors

Molecular Endocrinology

Volumn 11, Issue 4, 1997, Pages 470-480

  Yoh, Sunnie M ^a   Chatterjee, V K K ^b   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HORMONE RESISTANCE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0030988565     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.4.9914     Document Type: Article

References (64)

1. Carlson-Jurica, MA, Schrader WT, O'Malley BW 1990 Steroid receptor family: structure and function. Endocr Rev 11:201-220
2. Lazar MA 1993 Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14:184-193
3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 Overview: the nuclear receptor superfamily: the second decade. Cell 83:835-840
4. Mangelsdorf DJ, Evans RM 1995 The RXR heterodimers and orphan receptors Cell 83:841-850
5. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-858
6. Kastner P, Mark M, Chambon P 1995 Nonsteroidal nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-870
7. Damm K, Thompson CC, Evans RM 1989 Protein encoded by v-Erb A functions as a thyroid hormone receptor antagonist. Nature 339:593-597
8. Sap J, Munoz A, Schmitt H, Stunnenberg H, Vennstrom B 1989 Repression of transcription mediated by a thyroid hormone response element by the v-Erb A oncogene product. Nature 340:242-244
9. Privalsky ML, Sharif M, Yamamoto KR 1990 The viral Erb A oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast. Cell 63:1277-1286
10. Miner JN, Diamond MI, Yamamoto KR 1991 Transcriptional factor interactions: selectors of positive or negative regulation from a single DNA element. Cell Growth Differ 2:525-530
11. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
12. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamel Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
13. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
14. Sande S, Privalsky ML 1996 Identification of TRACs (T3 Receptor-associating cofactors) a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825
15. Chen JD, Umesono K, Evans RM 1996 SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93:7567-7571
16. Baniahmad A, Kohne AC, Renkawitz R 1992 A transferable silencing domain is present in the thyroid hormone receptor, in the v-Erb A oncogene product, and in the retinoic acid receptor. EMBO J 11:1015-1023
17. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au-Flieger M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HW 1994 Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoid acid receptors from an inhibitory cellular factor. Mol Cell Biol 14:5756-5765
18. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O'Malley BW 1995 The t4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86
19. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptors. EMBO J 14:3741-3751
20. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins- possible mediators of hormone-induced transcription. Science 264:1455-1458
21. Le Douari B, Zechel C, Gamier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 9:2020-2033
22. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD 1995 Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 374:91-94
23. Soel W, Choi WS, Moore DD 1995 Isolation of proteins that interact specificially with the retinoid × receptor: two novel orphan receptors. Mol Endocrinol 9:72-85
24. Onate SA, Tsai SY Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
25. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
26. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B 1986 The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324:635-640
27. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM 1986 The c-erbA gene encodes a thyroid hormone receptor. Nature 234:641-646
28. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVS, Dmitrovsky E, Evans R 1991 Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor. Cell 66:663-674
29. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A 1991 The PML-RARα fusion mRNA encodes a funcionally altered RAR. Cell 66:675-684
30. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD 1993 Genetic basis of endocrine disease 4: the spectrum of mutations in the androgen receptor gene that cause androgen resistance. J Clin Endocrinol Metab 76:17-23
31. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW 1988 Point mutations in the vitamin D receptor associated with hypocalcemic rickets. Science 242:1702-1705
32. Beck-Peccoz P, Chatterjee, VKK 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232
33. Refetoff S, Weiss RE, Usala S 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
34. Kopp P, Kitajima K, Jameson JL 1996 Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 211:49-61
35. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, Accili D, McBride OW, Weintraub BD 1988 Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erb Aβ gene. Mol Endocrinol 2:1217-1220
36. Sakurai AK, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ 1989 Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc Natl Acad Sci USA 86:8977-8991
37. Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accili D, Hauser P, Weintraub BD 1990 A base mutation of the c-erb Aβ thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest 85:93-100
38. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH, Weintraub BD 1991 Characterization of seven novel mutations of the c-erb Aβ gene in unrelated kindreds with generalized thyroid hormone resistance: evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest 88:2123-2130
39. Takeda K, Weiss RE, Refetoff S 1992 Rapid localization of mutations in the thyroid hormone receptor β gene by denaturing gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab 74:712-719
40. Chatterjee VKK, Nagaya T, Madison LD, Datta S, Rentoumis A, Jameson JL 1991 Thyroid hormone resistance syndrome: inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest 87:1977-1984
41. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao E-H, Usala SJ, Bercu BB, Cheng S-Y, Weintraub BD 1992 Variable transcriptional activity and ligand binding of mutant β1 3,5,3′ triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
42. Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ 1990 Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-β in a family with generalized resistance to thyroid hormone. Mol Endocrinol 4:1988-1994
43. Baniahmad A, Tsai SY, O'Malley BW, Tsai M-J 1992 Kindred S thyroid hormone receptor is an active and constitutive silencer and a represser for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci USA 89:10633-10637
44. Nagaya TN, Madison LD, Jameson JL 1992 Thyroid hormone receptor mutations that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. J Biol Chem 267:13014-13019
45. Yen PM, Sugawa A, Refetoff S, Chin WW 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptors in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
46. Nagaya T, Eberhardt NL, Jameson JL 1993 Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 77:982-990
47. Zavacki AM, Harney JW, Brent GA, Larsen PR 1993 Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol 7:1319-1330
48. Collingwood TN, Adams M, Tone Y, Chatterjee VKK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277
49. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee KK 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. J Clin Invest 94:506-515
50. Yen PM, Chin WW 1994 Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 8:1450-1454
51. Pohlenz J, Wirth S, Winterpacht A, Wemme H, Zabel B, Schonberger W 1995 Phenotypic variability in patients with generalized resistance to thyroid hormone. J Med Genet 32:393-395
52. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW, Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? J Clin Endocrinol Metab 80:3246-3256
53. Weiss RE, Marcocci C, Bruno-Bossio G, Refetoff S 1993 Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab 76:257-259
54. Wong R, Zhu XG, Pineda MA, Cheng SY, Weintraub BD 1995 Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors. Mol Med 1:306-319
55. Bigler J, Eisenman RN 1988 c-erbA encodes mutliple proteins in chicken erythroid cells. Mol Cell Biol 8:4155-4161
56. Keidel S, LeMotte P, Apfel C 1994 Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol Cell Biol 14:287-298
57. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
58. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
59. Forman BM, Umesono K, Chen J, Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550
60. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK 1994 Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531
61. Ausubel FM, Brent R, Kinston, RE Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current Protocols in Molecular Biology. Wiley & Sons Press, New York, pp 8.5.7-8.5.9
62. Ausubel FM, Brent R, Kinston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current Protocols in Molecular Biology. Wiley & Sons Press, New York, pp 9.1.1-9.1.3
63. Vivanco Ruiz MdM, Bugge TH, Hirschmann P, Stunnenberg HG 1991 Functional characterization of a natural retinoic acid responsive element. EMBO J 10:3829-3838
64. Vivanco Ruiz MdM, Johnson R, Galante PE, Hanahan D, Yamamoto KR 1995 A transistion in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development. EMBO J 14:2217-2228